Digestive Diseases and Sciences

, Volume 57, Issue 8, pp 2184–2194 | Cite as

Helicobacter Pylori Infection Increases the Risk of Colorectal Adenomas: Cross-Sectional Study and Meta-Analysis

  • Sung Noh Hong
  • Seung Min Lee
  • Jeong Han Kim
  • Tae Yoon Lee
  • Jeong Hwan Kim
  • Won Hyeok Choe
  • Sun-Young Lee
  • Young Koog Cheon
  • In Kyung Sung
  • Hyung Seok Park
  • Chan Sup Shim
Original Article



The studies concerning the association between Helicobacter pylori status and colorectal adenoma, premalignant lesions of colorectal cancers, are not consistent.


This cross-sectional study investigated the association of colorectal adenoma with H. pylori infection in a consecutive series of 2,195 asymptomatic average-risk subjects who underwent screening colonoscopy and H. pylori testing. Multivariate analyses were adjusted for potential relevant confounders, including age, sex, smoking, alcohol consumption, family history of colorectal cancer, and regular use of aspirin. Furthermore, we performed a systematic literature review and meta-analysis of available studies, including the current study, to clarify whether H. pylori infection is associated with an increased risk of colorectal adenoma.


Among 2,195 eligible subjects, 1,253 subjects were H. pylori seropositive and 942 subjects were seronegative. In the H. pylori (+) group, the prevalence of colorectal adenoma and advanced adenoma was significantly higher than in the H. pylori (−) group (25.3 vs. 20.1 %, p = 0.004 and 6.1 vs. 2.9 %, p < 0.001, respectively). In our multivariate analysis, H. pylori seropositivity was an independent risk factor for overall colorectal adenoma (OR = 1.36, 95 % CI = 1.10–1.68) and advanced adenoma (OR = 2.21, 95 % CI = 1.41–3.48). The positive association was confined in cases with any proximal adenoma. In the meta-analysis, which included ten studies and 15,863 patients, the pooled OR for colorectal adenoma related to H. pylori infection was 1.58 (95 % CI = 1.32–1.88).


Our results from this cross-sectional study and current studies included in our meta-analysis indicated that H. pylori infection was associated with a modest increase in the risk for colorectal adenoma.


Colorectal neoplasms Helicobacter pylori Cross-sectional analysis Meta-analysis 



Colorectal cancer


Odds ratio


Confidence interval

Helicobacter pylori

H. pylori



This work was supported by the Konkuk University Medical Center Research Grant 2009.

Conflict of interest

No conflicts of interest exist.


  1. 1.
    Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.PubMedCrossRefGoogle Scholar
  2. 2.
    Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med. 1992;326:658–662.PubMedCrossRefGoogle Scholar
  3. 3.
    Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The national polyp study workgroup. N Engl J Med. 1993;329:1977–1981.PubMedCrossRefGoogle Scholar
  4. 4.
    Collins D, Hogan AM, Winter DC. Microbial and viral pathogens in colorectal cancer. Lancet Oncol. 2011;12:504–512.PubMedCrossRefGoogle Scholar
  5. 5.
    Jones M, Helliwell P, Pritchard C, et al. Helicobacter pylori in colorectal neoplasms: is there an aetiological relationship? World J Surg Oncol. 2007;5:51.PubMedCrossRefGoogle Scholar
  6. 6.
    Grahn N, Hmani-Aifa M, Fransen K, et al. Molecular identification of helicobacter DNA present in human colorectal adenocarcinomas by 16s rDNA PCR amplification and pyrosequencing analysis. J Med Microbiol. 2005;54:1031–1035.PubMedCrossRefGoogle Scholar
  7. 7.
    Shmuely H, Passaro D, Figer A, et al. Relationship between Helicobacter pylori CagA status and colorectal cancer. Am J Gastroenterol. 2001;96:3406–3410.PubMedCrossRefGoogle Scholar
  8. 8.
    Hartwich A, Konturek SJ, Pierzchalski P, et al. Helicobacter pylori infection, gastrin, cyclooxygenase-2, and apoptosis in colorectal cancer. Int J Colorectal Dis. 2001;16:202–210.PubMedCrossRefGoogle Scholar
  9. 9.
    Konturek SJ, Konturek PC, Hartwich A, et al. Helicobacter pylori infection and gastrin and cyclooxygenase expression in gastric and colorectal malignancies. Regul Pept. 2000;93:13–19.PubMedCrossRefGoogle Scholar
  10. 10.
    Marotta F, Hayakawa K, Mikami Y, et al. Relationship between gastrin cell number, serum, antral mucosa and luminal gastrin concentration and gastric acidity in antral atrophic gastritis. Gut. 1990;31:279–281.PubMedCrossRefGoogle Scholar
  11. 11.
    Niv Y. Gastrin and colorectal neoplasia: cause and effect. Digestion. 2006;74:40–41.PubMedCrossRefGoogle Scholar
  12. 12.
    Zhao YS, Wang F, Chang D, et al. Meta-analysis of different test indicators: Helicobacter pylori infection and the risk of colorectal cancer. Int J Colorectal Dis. 2008;23:875–882.PubMedCrossRefGoogle Scholar
  13. 13.
    Zumkeller N, Brenner H, Zwahlen M, et al. Helicobacter pylori infection and colorectal cancer risk: a meta-analysis. Helicobacter. 2006;11:75–80.PubMedCrossRefGoogle Scholar
  14. 14.
    Abbass K, Gul W, Beck G, et al. Association of Helicobacter pylori infection with the development of colorectal polyps and colorectal carcinoma. South Med J. 2011;104:473–476.PubMedCrossRefGoogle Scholar
  15. 15.
    Aydin A, Karasu Z, Zeytinoglu A, et al. Colorectal adenomateous polyps and Helicobacter pylori infection. Am J Gastroenterol. 1999;94:1121–1122.PubMedCrossRefGoogle Scholar
  16. 16.
    Bae RC, Jeon SW, Cho HJ, et al. Gastric dysplasia may be an independent risk factor of an advanced colorectal neoplasm. World J Gastroenterol. 2009;15:5722–5726.PubMedCrossRefGoogle Scholar
  17. 17.
    Breuer-Katschinski B, Nemes K, Marr A, et al. Helicobacter pylori and the risk of colonic adenomas. Colorectal adenoma study group. Digestion. 1999;60:210–215.PubMedCrossRefGoogle Scholar
  18. 18.
    Fujimori S, Kishida T, Kobayashi T, et al. Helicobacter pylori infection increases the risk of colorectal adenoma and adenocarcinoma, especially in women. J Gastroenterol. 2005;40:887–893.PubMedCrossRefGoogle Scholar
  19. 19.
    Lin YL, Chiang JK, Lin SM, et al. Helicobacter pylori infection concomitant with metabolic syndrome further increase risk of colorectal adenomas. World J Gastroenterol. 2010;16:3841–3846.PubMedCrossRefGoogle Scholar
  20. 20.
    Mizuno S, Morita Y, Inui T, et al. Helicobacter pylori infection is associated with colon adenomatous polyps detected by high-resolution colonoscopy. Int J Cancer. 2005;117:1058–1059.PubMedCrossRefGoogle Scholar
  21. 21.
    Moss SF, Neugut AI, Garbowski GC, et al. Helicobacter pylori seroprevalence and colorectal neoplasia: evidence against an association. J Natl Cancer Inst. 1995;87:762–763.PubMedCrossRefGoogle Scholar
  22. 22.
    Siddheshwar RK, Muhammad KB, Gray JC, et al. Seroprevalence of Helicobacter pylori in patients with colorectal polyps and colorectal carcinoma. Am J Gastroenterol. 2001;96:84–88.PubMedCrossRefGoogle Scholar
  23. 23.
    Inoue I, Mukoubayashi C, Yoshimura N, et al. Elevated risk of colorectal adenoma with Helicobacter pylori-related chronic gastritis: a population-based case-control study. Int J Cancer. 2011;129:2704–2711.PubMedCrossRefGoogle Scholar
  24. 24.
    Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112:2735–2752.PubMedCrossRefGoogle Scholar
  25. 25.
    Kim HY, Kim N, Kang JM, et al. Clinical meaning of pepsinogen test and Helicobacter pylori serology in the health check-up population in Korea. Eur J Gastroenterol Hepatol. 2009;21:606–612.PubMedCrossRefGoogle Scholar
  26. 26.
    Bosman FT, Carneiro F, Hruban RH. WHO Classification of Tumours of the Digestive System, 4th ed. Lyon: WHO Press; 2010.Google Scholar
  27. 27.
    Lehours P, Yilmaz O. Epidemiology of Helicobacter pylori infection. Helicobacter. 2007;12:1–3.PubMedCrossRefGoogle Scholar
  28. 28.
    Williams MP, Pounder RE. Helicobacter pylori: from the benign to the malignant. Am J Gastroenterol. 1999;94:S11–S16.PubMedCrossRefGoogle Scholar
  29. 29.
    Yamaoka Y, Kato M, Asaka M. Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains. Intern Med. 2008;47:1077–1083.PubMedCrossRefGoogle Scholar
  30. 30.
    Takeda H, Asaka M. Helicobacter pylori and colorectal neoplasm: a mysterious link? J Gastroenterol. 2005;40:919–920.PubMedCrossRefGoogle Scholar
  31. 31.
    Robertson DJ, Sandler RS, Ahnen DJ, et al. Gastrin, Helicobacter pylori, and colorectal adenomas. Clin Gastroenterol Hepatol. 2009;7:163–167.PubMedCrossRefGoogle Scholar
  32. 32.
    Argent RH, Hale JL, El-Omar EM, et al. Differences in Helicobacter pylori CagA tyrosine phosphorylation motif patterns between western and East Asian strains, and influences on interleukin-8 secretion. J Med Microbiol. 2008;57:1062–1067.PubMedCrossRefGoogle Scholar
  33. 33.
    Correa P, Miller MJ. Helicobacter pylori and gastric atrophy-cancer paradoxes. J Natl Cancer Inst. 1995;87:1731–1732.PubMedCrossRefGoogle Scholar
  34. 34.
    Thorburn CM, Friedman GD, Dickinson CJ, et al. Gastrin and colorectal cancer: a prospective study. Gastroenterology. 1998;115:275–280.PubMedCrossRefGoogle Scholar
  35. 35.
    Smith AM, Watson SA. Review article: gastrin and colorectal cancer. Aliment Pharmacol Ther. 2000;14:1231–1247.PubMedCrossRefGoogle Scholar
  36. 36.
    Colucci R, Blandizzi C, Tanini M, et al. Gastrin promotes human colon cancer cell growth via CCK-2 receptor-mediated cyclooxygenase-2 induction and prostaglandin E2 production. Br J Pharmacol. 2005;144:338–348.PubMedCrossRefGoogle Scholar
  37. 37.
    McNulty CA, Lehours P, Megraud F. Diagnosis of Helicobacter pylori infection. Helicobacter. 2011;16:10–18.PubMedCrossRefGoogle Scholar
  38. 38.
    Obata Y, Kikuchi S, Miwa H, et al. Diagnostic accuracy of serological kits for Helicobacter pylori infection with the same assay system but different antigens in a Japanese patient population. J Med Microbiol. 2003;52:889–892.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Sung Noh Hong
    • 1
    • 2
    • 3
  • Seung Min Lee
    • 1
  • Jeong Han Kim
    • 1
  • Tae Yoon Lee
    • 1
  • Jeong Hwan Kim
    • 1
    • 3
  • Won Hyeok Choe
    • 1
  • Sun-Young Lee
    • 1
  • Young Koog Cheon
    • 1
  • In Kyung Sung
    • 1
  • Hyung Seok Park
    • 1
  • Chan Sup Shim
    • 1
    • 2
  1. 1.Department of Internal MedicineKonkuk University School of MedicineSeoulRepublic of Korea
  2. 2.Healthcare CenterKonkuk University Medical CenterSeoulKorea
  3. 3.Medical Immunology Center, Institute of Biomedical Science and TechnologyKonkuk University School of MedicineSeoulKorea

Personalised recommendations